Kidney Carcinoma
We recommend
Prognostic Model MSKCC in Patients with Metastatic Renal Carcinoma Treated in 1st Line with Sunitinib
A study by Czech authors published in 2020 demonstrated the usefulness of the MSKCC (Memorial Sloan Kettering Cancer Center) model in the prognostic stratification of patients with metastatic renal carcinoma (mRCC) treated with sunitinib in the 1st line. Additionally, a significant difference was found between the outcomes achieved in patients with intermediate risk who had one or two risk factors.
Risk Factors for Renal Cancer Formation After Kidney Transplantation
German authors in the below-cited work identified modifiable risk factors associated with the…
Kidney Carcinoma – Key Facts About the Disease With the Highest Incidence Worldwide in the Czech Republic
The incidence of renal carcinoma is increasing every year. About a quarter of the cases are still…
Articles on this topic
Expression of PD-L1 as a Predictive Biomarker for Therapy Selection in mRCC
A newly published systematic review and meta-analysis of studies involving patients with…
Efficacy and Safety of Axitinib in Higher Lines of Renal Carcinoma Treatment in Real Practice
Greek authors published a retrospective study from a single institution and demonstrated that…
Journal articles Examination of circulating tumor cells in renal carcinoma
Zařazení vyšetření na cirkulující nádorové buňky do běžného algoritmu vyšetření u pacientů po operaci...
Journal articles Cystic renal lesions: one centre study
Byli vyhledáni a opětovně hodnoceni pacienti léčení chirurgicky pro tumor ledviny/ cystickou renální...
Journal articles Case report of a gigantic recurrent angiomyolipoma in a horseshoe kidney
Prezentujeme kazuistiku objemného recidivujícího angiomyolipomu podkovovité ledviny u mladé pacientky...
Subscribe
Most read on this topic
Journal on this topic
Related topic
Most read on this topic
- Cystic renal lesions: one centre study
- Kidney Carcinoma – Key Facts About the Disease With the Highest Incidence Worldwide in the Czech Republic
- Expression of PD-L1 as a Predictive Biomarker for Therapy Selection in mRCC
- Examination of circulating tumor cells in renal carcinoma
- Prognostic Model MSKCC in Patients with Metastatic Renal Carcinoma Treated in 1st Line with Sunitinib
- Risk Factors for Renal Cancer Formation After Kidney Transplantation
Journal on this topic
Related topic